Silver sulphadiazene: an adjunct to central line maintenance protocol.
Bentivegna
P E
PE
D002056:Burns / Q000188:drug therapy*; D002406:Catheterization, Peripheral / Q000009:adverse effects*; D006801:Humans; D010689:Phlebitis / Q000209:etiology / Q000517:prevention & control*; D012837:Silver Sulfadiazine / Q000627:therapeutic use*; D013411:Sulfadiazine / Q000627:therapeutic use*
D013411:Sulfadiazine; D012837:Silver Sulfadiazine